← Eichor
Condition: Interstitial Lung Disease Ild Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Interstitial Lung Disease Ild

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
NA · 1 location(s) · MGH Institute of Health Professions · NCT06304207Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Phase 3 · 11 location(s) · Baylor College of Medicine · NCT02670707Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias
NA · 1 location(s) · University Hospital, Bordeaux · NCT07283081Dorothy P. and Richard P. Simmons Center for ILD Research Registry
Phase N/A · 1 location(s) · University of Pittsburgh · NCT00258583Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00001456Optimization of the Time and Dosage of Trametinib in BRAF Negative Juvenile Patients
Phase 2 · 1 location(s) · Anna Raciborska · NCT04943224Mechanisms of Familial Pulmonary Fibrosis
Phase N/A · 1 location(s) · Vanderbilt University Medical Center · NCT03437486The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis
NA · 1 location(s) · Saglik Bilimleri Universitesi · NCT07320846PROOF OF CONCEPT STUDY ON THE EFFICACY OF INHALATORY TARGETED IMATINIB NANOFORMULATIONS IN PULMONARY HYPERTENSION AND PO
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT06917196The Role of Standardized Training in the Diagnosis of Interstitial Lung Disease by Transbronchial Lung Cryobiopsy
NA · 1 location(s) · China-Japan Friendship Hospital · NCT06245954The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
Phase N/A · 1 location(s) · University of Virginia · NCT06323876Functional MRI for Monitoring Progression and Assessing Trends in ILD
NA · 2 location(s) · University Hospital Heidelberg · NCT07300696Hydroxychloroquine as a Steroid-sparing Agent in Extrapulmonary Sarcoidosis
Phase 4 · 21 location(s) · Hospices Civils de Lyon · NCT05841758An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Phase N/A · 23 location(s) · Liquidia Technologies, Inc. · NCT06129240An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Phase 2 · 54 location(s) · Avalyn Pharma Inc. · NCT06951217AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Phase 2 · 3 location(s) · Avalyn Pharma Inc. · NCT07194382Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
Phase N/A · 1 location(s) · University of Pittsburgh · NCT00258570Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis
Phase 2 · 1 location(s) · University of Wisconsin, Madison · NCT06940427H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Phase 2 · 1 location(s) · National Institute of Environmental Health Sciences (NIEHS) · NCT06325696Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
NA · 2 location(s) · Skane University Hospital · NCT06247397Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
EARLY_Phase 1 · 1 location(s) · University of Virginia · NCT06853145Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Phase 3 · 1 location(s) · Argyrios Tzouvelekis · NCT07299695Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
Phase 1 · 1 location(s) · University of Alabama at Birmingham · NCT04362644Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib
Phase 2 · 1 location(s) · Cook Children's Health Care System · NCT06582745Magnetic Resonance Imaging of the Lung: Non-Oncological Applications
Phase N/A · 1 location(s) · Fondazione IRCCS Policlinico San Matteo di Pavia · NCT07493187A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Int
Phase 2 · 19 location(s) · AllRock Bio, Inc. · NCT07175038Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses
Phase N/A · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT03329274Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis
NA · 11 location(s) · West China Second University Hospital · NCT07431060Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases
Phase 2/Phase 3 · 33 location(s) · R-Pharm International, LLC · NCT06440746A Study of the Pharmacokinetics and Safety of Single-dose Inhaled RJ026 in Healthy Volunteers and Patients With Intersti
Phase 1 · 1 location(s) · Ruijin Hospital · NCT06992661
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.